findmyKOL

Benedict Maliakkal, MD

Basic profile

Meharry Medical College

ORCIDNone on fileNPI↗
✓ Full record
RegionMemphis, TN · SoutheastSpecialtyGastroenterologyFocusGastroenterology
Active KOLfindmyKOL type: RegionalLatest publication2020Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Benedict Maliakkal is a Gastroenterology physician affiliated with Meharry Medical College. OpenAlex indexes 166 publications with 5,693 citations (h-index 35); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
166publications

Distinct works indexed by OpenAlex.

5,693citations

Total citations across indexed works.

35h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
17companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1265 Union Ave
Suite 184
Memphis, TN 381043415

Telephone

901-516-9183

Registry record last updated 30 Aug 2016.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    51%
    Rifamycin Antibacterial12.7%
    Xifaxan100%
    Part D<11 patients
    Proton pump inhibitor11.6%
    Pantoprazole Sodium100%
    Part D<11 patients

    + 4 more classes in this area

  • Cardiovascular

    34%
    Beta blocker14.7%
    Carvedilol100%
    Part D≥13 patients
    Aldosterone antagonist (MRA)13.9%
    Spironolactone100%
    Part D≥12 patients

    + 1 more class in this area

  • Cancer & immunology

    10.4%
    Calcineurin inhibitor6.2%
    Tacrolimus100%
    Part D<11 patients
    Nonsteroidal Anti-inflammatory Drug4.2%
    Celecoxib100%
    Part D<11 patients
Where care is delivered (Part B)26.2% facility · 73.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”